| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.11B | 28.85B | 24.95B | 22.00B | 20.39B | 18.04B |
| Gross Profit | 7.12B | 7.33B | 6.86B | 5.68B | 4.57B | 4.18B |
| EBITDA | 2.44B | 2.59B | 2.40B | 2.04B | 1.14B | 936.84M |
| Net Income | 2.86B | 2.03B | 2.91B | 1.96B | 3.97B | 828.07M |
Balance Sheet | ||||||
| Total Assets | 94.77B | 93.06B | 91.10B | 85.75B | 83.56B | 96.28B |
| Cash, Cash Equivalents and Short-Term Investments | 3.31B | 2.93B | 4.06B | 2.84B | 4.54B | 1.78B |
| Total Debt | 796.16M | 4.40M | 536.01M | 862.12M | 1.26B | 2.09B |
| Total Liabilities | 24.40B | 23.20B | 23.15B | 21.95B | 21.49B | 26.59B |
| Stockholders Equity | 70.37B | 69.85B | 67.95B | 63.81B | 62.06B | 69.69B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 65.98M | 1.95B | 885.97M | 3.79B | 684.21M |
| Operating Cash Flow | 0.00 | 3.07B | 3.94B | 2.76B | 5.34B | 2.38B |
| Investing Cash Flow | 0.00 | -3.42B | -2.07B | -1.84B | -1.56B | -1.76B |
| Financing Cash Flow | 0.00 | -1.18B | -653.71M | -2.61B | -1.02B | -108.53M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥68.23B | 7.81 | ― | 1.55% | 6.02% | 5.87% | |
69 Neutral | ¥48.79B | 12.53 | ― | 4.63% | 8.98% | 2.01% | |
65 Neutral | ¥210.40B | 12.79 | 13.33% | 3.47% | 3.37% | 5.12% | |
65 Neutral | ¥29.35B | 12.93 | ― | 1.23% | 5.09% | 10.97% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ¥35.67B | 16.19 | ― | 0.84% | 15.61% | -29.18% | |
49 Neutral | ¥59.88B | 513.85 | ― | 1.14% | 9.13% | -21.27% |